[
  {
    "ts": null,
    "headline": "Venture financing for mRNA-based vaccines declines 82% in 2025 YTD",
    "summary": "Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.",
    "url": "https://finnhub.io/api/news?id=aae9b6d6445a31bed6a4f562bd683198b440127972198066877d62432c14d0e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759832071,
      "headline": "Venture financing for mRNA-based vaccines declines 82% in 2025 YTD",
      "id": 136999221,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.",
      "url": "https://finnhub.io/api/news?id=aae9b6d6445a31bed6a4f562bd683198b440127972198066877d62432c14d0e5"
    }
  }
]